PRESS RELEASE published on 05/29/2025 at 14:30, 1 year 2 months ago Press Release: Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs Real-world comparison shows Beyfortus and RSVpreF immunization programs reduce infant RSV hospitalizations in Spain and UK. Beyfortus provides sustained protection against RSV with high efficacy and safety profile RSV Beyfortus RSVpreF Infant Immunization
BRIEF published on 05/22/2025 at 01:20, 1 year 2 months ago Sanofi acquiert Vigil Neuroscience pour renforcer sa recherche sur Alzheimer Acquisition Maladie D'Alzheimer Sanofi Neurologie Vigil Neuroscience
BRIEF published on 05/22/2025 at 01:20, 1 year 2 months ago Sanofi acquires Vigil Neuroscience to strengthen its Alzheimer's research Acquisition Alzheimer's Disease Sanofi Neurology Vigil Neuroscience
PRESS RELEASE published on 05/22/2025 at 01:15, 1 year 2 months ago Communiqué de presse : Sanofi va acquérir Vigil Neuroscience, Inc. et ajouter un nouveau médicament expérimental pour le traitement de la maladie d’Alzheimer à son portefeuille en neurologie Sanofi annonce l'acquisition de Vigil Neuroscience, Inc. pour développer un médicament expérimental contre la maladie d'Alzheimer. Renforcement du portefeuille en neurologie Acquisition Maladie D'Alzheimer Sanofi Neurologie Vigil Neuroscience
PRESS RELEASE published on 05/22/2025 at 01:15, 1 year 2 months ago Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline Sanofi acquires Vigil Neuroscience to enhance neurology pipeline with an investigational medicine for Alzheimer's disease. The acquisition includes VG-3927, a small molecule TREM2 agonist Alzheimer's Disease Sanofi Neurology Vigil Neuroscience VG-3927
BRIEF published on 05/15/2025 at 19:11, 1 year 2 months ago Sanofi : Détails sur les Droits de Vote et Actions - Avril 2025 Investissement Droits De Vote Actions Sanofi Avril 2025
BRIEF published on 05/15/2025 at 19:11, 1 year 2 months ago Sanofi: Details on Voting Rights and Shares - April 2025 Voting Rights Actions Investment Sanofi April 2025
PRESS RELEASE published on 05/15/2025 at 19:06, 1 year 2 months ago Sanofi: Informations relatives au nombre de droits de vote et d'actions - Avril 2025 Publication des droits de vote et actions de Sanofi selon les réglementations financières en vigueur Autorité Des Marchés Financiers Droits De Vote Code De Commerce Actions Sanofi
BRIEF published on 04/30/2025 at 13:05, 1 year 3 months ago Sanofi et CD&R finalisent la cession d'Opella Cession Sanofi CD&R Opella Santé Grand Public
BRIEF published on 04/30/2025 at 13:05, 1 year 3 months ago Sanofi and CD&R finalize the sale of Opella Sanofi CD&R Assignment Opella Consumer Health
Published on 08/03/2026 at 23:00, 8 hours 54 minutes ago Viemed Healthcare Announces Second Quarter 2026 Financial Results
Published on 08/01/2026 at 01:58, 3 days 5 hours ago Clôture de l'option sur la propriété de graphite au Québec
Published on 08/01/2026 at 01:20, 3 days 6 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 3 days 6 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 3 days 7 hours ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 08/04/2026 at 07:38, 16 minutes ago Elmos Semiconductor SE continues strong operating performance in the first half of 2026
Published on 08/04/2026 at 07:30, 24 minutes ago Nordex Group secures new U.S. orders totaling more than 480 MW
Published on 08/04/2026 at 07:30, 24 minutes ago Continental Enters Final Phase of Realignment with Strong Second Quarter
Published on 08/04/2026 at 07:15, 39 minutes ago EQS-Adhoc: ams-OSRAM AG: ams OSRAM delivers Q2 at guidance high end and readies microLED arrays for next-generation AR smart glasses
Published on 08/04/2026 at 07:00, 53 minutes ago Zalando delivers another quarter of profitable growth in Q2, accelerates B2B expansion and continues innovating through AI
Published on 08/03/2026 at 18:45, 13 hours 9 minutes ago Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 08/03/2026 at 18:45, 13 hours 9 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 08/03/2026 at 18:35, 13 hours 19 minutes ago Covivio Hotels - Informations relatives au nombre total de droits de vote et d'actions composant le capital social